Ferric Citrate and Chronic Kidney Disease in Children
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 160 participants.
Also called NCT04741646
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 160 participants
- Sponsor
- Registry
-
NCT04741646
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04741646. Randomized; quadruple masking; primary purpose treatment. Start 2022-06-17 (actual); primary completion 2027-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ferric Citrate and Chronic Kidney Disease in Children
- Acronym
- FIT4KID
- Condition
- Chronic Kidney Diseases
- Intervention (Drug)
- Ferric Citrate
- Intervention (Drug)
- Placebo
- Lead sponsor
- University of California, Los Angeles
- Collaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Record details
- Record id
cardio:ct-nct04741646- Content hash
4f39b8e5b750bee11bc5c9b3a9fb6c97f87d5057602598a93ba1dec313830fc9